Consumers will decide the winners and losers of retail health
Retail health is getting more attention from entrepreneurs and investors, as consumers become activists in purchasing our goods and services.
The Herculean task of managing Medicaid and the biggest challenges to come
If Medicare is the elephant in the room in health reform, Medicaid is next.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
A look into healthcare’s future: Here’s what will matter in medicine in 2016
Smartphones will be medical devices and healthcare will be a Top 3 presidential campaign issue.
As consolidation forces health systems to get bigger, how are they managing risk?
For healthcare providers, the transition to big is not without risk, but the greater risk is to be run over by the big’s.
Understand everything about primary care or you’ll never grasp the future of medicine
Primary care is the frontline in health reform and is much bigger than physicians that see patients for their ailments and minor emergencies.
Anthem and Aetna know this: Reputation (not just big dollars) matter
Anthem and Aetna are in Washington, D.C. There's more than politics and mergers at stake.
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
How will Donald Trump’s brand of political theater play out with healthcare?
What if Donald Trump had zeroed in on healthcare in Mobile? It’s a market where big players dominate and consumer choice is limited.
Here are some of the complexities of the drug cost debate
How is drug effectiveness determined? How do formulary designs, coverage decisions by PBMs, and third party reviews assess the efficacy and effectiveness of drugs?
Physician survey: Physician leaders accept healthcare reform but wary about future
These are the best and the worst of times for the profession, and the most challenging for its leaders.
How is Medicare coping with its midlife crisis?
Medicare plays a central role in our country’s social contract with its seniors.
Maximize Revenue and Patient Care with Strategic Weight Loss Management
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Looking beyond King v Burwell, 8 healthcare reform issues to occupy our attention
Health reform is much more than the ACA. There are eight overarching issues to follow in coming weeks and months.
This is why Moneyball is analogous to healthcare
Healthcare is a big business. It’s made fortunes for inventors who hold patents to medicines, apps and technologies and for investors who bet on for-profit hospitals, big IT platforms and others.
Healthcare’s true challenge: Act like it sells dresses, groceries and Blu-ray
It's not volume to value. It's consumer-driven healthcare.
Read this Obamacare analysis and you can ignore every other 5-year ACA anniversary story
The following post originally appears in Pulse Weekly, a weekly take on the industry from Paul Keckley and the Navigant Healthcare Center for Research and Policy. Five years ago today, The Patient Protection and Affordable Care Act (PPACA), or Affordable Care Act (ACA) as it is more widely known, was passed by the 111th Congress and […]
Healthcare innovators will thrive no matter what happens to Obamacare in King v. Burwell
What intrigues me the most about these scenarios are the innovators who see healthcare uncertainty as an opportunity, regardless of the court’s decision. CVS Health defines health and wellbeing as its cause, expanding its 970 retail clinics by 500 in the next two years and empowering its pharmacists and their teams to manage health. TeleDoc and others see leverage though distance medicine. Health systems believe in taking on risk rather than avoiding it, and investors are making big bets in technology-enabled care. There’s no shortage of enthusiasm about the “new normal” among these and others who translate the court’s deliberation as no more than a wrinkle to be managed.